ILS develops antibodies against Chikungunya infection

The Institute of Life Sciences(ILS) has successfully developed antibodies against the Chikungunya virus(CHIKV) infection. The antibodies were developed following decade-long research on the CHIKV infection at the ILS laboratory. With no prior antibodies reported against CHIKV,the group was the first to develop antibodies against the non-structural proteins – nsP1,nsP3 and nsP4 of CHIKV. This development… Continue reading ILS develops antibodies against Chikungunya infection